Iovance Biotherapeutics

IOVANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$2.831 B

$6.34 +2.09%

Close of 7 Aug 2026

Revenue

$263.5M

#2198 by revenue

Earnings

-$391.0M

Loss-making

Shares outstanding

452,971,432

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#27Kodiak SciencesKOD$2.84B
#28Beam TherapeuticsBEAM$2.84B
#29Iovance BiotherapeuticsIOVA$2.83B
#30Tarsus PharmaceuticalsTARS$2.79B
#31Biocryst PharmaceuticalsBCRX$2.40B

Where these numbers come from

Share counts and financials for Iovance Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.